Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Andrology

  Free Subscription


Articles published in Int J Clin Pract

Retrieve available abstracts of 42 articles:
HTML format



Single Articles


    April 2021
  1. KILIC T, Kilic Aydin N, Kirici Berber N, Kaya O, et al
    Evaluation of erectile dysfunction in patients with asthma.
    Int J Clin Pract. 2021 Apr 30:e14300. doi: 10.1111/ijcp.14300.
    PubMed     Abstract available


  2. MINANA B, Molero JM, Agra Rolan A, Martinez-Fornes MT, et al
    Real-world therapeutic management and evolution of patients with benign prostatic hyperplasia in primary care and urology in Spain.
    Int J Clin Pract. 2021 Apr 22:e14250. doi: 10.1111/ijcp.14250.
    PubMed     Abstract available


    March 2021
  3. DUYMAZ G, Ozgur T, Giray Kara A, Erdem V, et al
    Relationship Between Daily Testosterone Production and Bi-spectral Index (BIS) Values in Patients Who Underwent Septoplasty Operation.
    Int J Clin Pract. 2021 Mar 13:e14149. doi: 10.1111/ijcp.14149.
    PubMed     Abstract available


    January 2021
  4. DASDEMIR ILKHAN G, Celikhisar H, Ilhan Alp S
    Premature ejaculation in osas: does it improve with cpap treatment?
    Int J Clin Pract. 2021 Jan 26:e14048. doi: 10.1111/ijcp.14048.
    PubMed     Abstract available


    November 2020
  5. LEE LJ, Maguire TA, Maculaitis MC, Emir B, et al
    Increasing Access to Erectile Dysfunction Treatment via Pharmacies to Improve Healthcare Provider Visits and Quality of Life: Results from a Prospective Real-World Observational Study in the United Kingdom.
    Int J Clin Pract. 2020 Nov 21:e13849. doi: 10.1111/ijcp.13849.
    PubMed     Abstract available


    October 2020
  6. TARIQ H, Zahid N, Amir D, Ashraf M, et al
    Estimation of folic acid/micro nutrients levels; does it reflect sperm parameters.
    Int J Clin Pract. 2020 Oct 30:e13790. doi: 10.1111/ijcp.13790.
    PubMed     Abstract available


    September 2020
  7. SHEN YC, Wang HJ, Lee WC, Chen CH, et al
    Intravesical prostatic protrusion does not compromise the therapeutic effects of Mirabegron in male patients with overactive bladder.
    Int J Clin Pract. 2020;74:e13537.
    PubMed     Abstract available


    August 2020
  8. SINGH I, Tk A, Gupta S
    Efficacy and safety of tadalafil vs tamsulosin in lower urinary tract symptoms (LUTS) as a result of benign prostate hyperplasia (BPH)-open label randomised controlled study.
    Int J Clin Pract. 2020;74:e13530.
    PubMed     Abstract available


    July 2020
  9. LIVINGSTON M, Downie P, Hackett G, Marrington R, et al
    An Audit of the Measurement and Reporting of Male Testosterone Levels in UK Clinical Biochemistry Laboratories.
    Int J Clin Pract. 2020 Jul 10:e13607. doi: 10.1111/ijcp.13607.
    PubMed     Abstract available


  10. MARIA MOLERO J, Minana B, Palacios-Moreno JM, Martinez-Fornes MT, et al
    Real-world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain.
    Int J Clin Pract. 2020 Jul 1. doi: 10.1111/ijcp.13602.
    PubMed     Abstract available


  11. NA Y, Htwe M, Rehman CA, Palmer T, et al
    Sexual dysfunction after stroke-A biopsychosocial perspective.
    Int J Clin Pract. 2020;74:e13496.
    PubMed     Abstract available


    June 2020
  12. RAFAQAT W, Kayani MR, Fatima T, Shaharyar S, et al
    Association of polymorphism c.-124G>A and c.-16 C>T in the promoter region of human INHA gene with altered sperm parameters; a pilot study.
    Int J Clin Pract. 2020 Jun 27:e13595. doi: 10.1111/ijcp.13595.
    PubMed     Abstract available


  13. TOPAKTAS R, Tokuc E, Kutluhan MA, Akyuz M, et al
    Clinical features and outcomes of COVID-19 patients with benign prostatic hyperplasia in aging male: A retrospective study of 18 cases.
    Int J Clin Pract. 2020 Jun 7:e13574. doi: 10.1111/ijcp.13574.
    PubMed     Abstract available


    May 2020
  14. REHMAN R, Zafar A, Fatima SS, Mohib A, et al
    Altered Sperm Parameters and Subclinical hypothyroidism; a cross sectional study in Karachi, Pakistan.
    Int J Clin Pract. 2020 May 26:e13555. doi: 10.1111/ijcp.13555.
    PubMed     Abstract available


  15. STEDMAN M, Whyte MB, Lunt M, Albanese M, et al
    The treatment rate of erectile dysfunction (ED) in younger men with Type 2 Diabetes is up to 4 times higher than the equivalent non-diabetes population.
    Int J Clin Pract. 2020 May 19:e13538. doi: 10.1111/ijcp.13538.
    PubMed     Abstract available


    March 2020
  16. AL RAWASHDAH SF, Pastore AL, Velotti G, Fuschi A, et al
    Sexual and functional outcomes of prostate artery embolisation: A prospective long-term follow-up, large cohort study.
    Int J Clin Pract. 2020;74:e13454.
    PubMed     Abstract available


    January 2020
  17. ROEHRBORN CG, Rosen RC, Manyak MJ, Palacios-Moreno JM, et al
    Men's Sexual Health Questionnaire score changes versus spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a post hoc ana
    Int J Clin Pract. 2020 Jan 11:e13480. doi: 10.1111/ijcp.13480.
    PubMed     Abstract available


  18. LIN H, Zhao L, Wu H, Cao M, et al
    Sexual life and medication taking behaviours in young men: An online survey of 92 620 respondents in China.
    Int J Clin Pract. 2020;74:e13417.
    PubMed     Abstract available


    October 2019
  19. MENG J, Liu Y, Guan SY, Ma H, et al
    Age, height, BMI and FBG predict prostate volume in ageing benign prostatic hyperplasia: Evidence from 5285 patients.
    Int J Clin Pract. 2019 Oct 21:e13438. doi: 10.1111/ijcp.13438.
    PubMed     Abstract available


    September 2019
  20. SHIMA Y, Kawano Y, Kobayashi A, Yamanishi T, et al
    Comparison of the clinical effect of dutasteride therapy for benign prostatic hyperplasia when initiated at different time points: a multicentre, observational, retrospective chart review study.
    Int J Clin Pract. 2019 Sep 11. doi: 10.1111/ijcp.13418.
    PubMed     Abstract available


    August 2019
  21. GOLDSTEIN I, Goren A, Li VW, Maculaitis MC, et al
    The association of erectile dysfunction with productivity and absenteeism in eight countries globally.
    Int J Clin Pract. 2019 Aug 6:e13384. doi: 10.1111/ijcp.13384.
    PubMed     Abstract available


    May 2019
  22. GOLDSTEIN I, Goren A, Liebert R, Tang WY, et al
    National Health and Wellness Survey exploratory cluster analysis of males 40-70 years old focused on erectile dysfunction and associated risk factors across the US, Italy, Brazil, and China.
    Int J Clin Pract. 2019 May 23:e13376. doi: 10.1111/ijcp.13376.
    PubMed     Abstract available


    November 2018
  23. PAYNE H, McMenemin R, Bahl A, Greene D, et al
    Measuring testosterone and testosterone replacement therapy in men receiving androgen deprivation therapy for prostate cancer: A survey of UK uro-oncologists' opinions and practice.
    Int J Clin Pract. 2018 Nov 10:e13292. doi: 10.1111/ijcp.13292.
    PubMed     Abstract available


    October 2018
  24. ROSEN RC, Roehrborn CG, Manyak MJ, Palacios-Moreno JM, et al
    Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH): a post hoc analysis of a prospective randomized placebo-c
    Int J Clin Pract. 2018 Oct 13:e13282. doi: 10.1111/ijcp.13282.
    PubMed     Abstract available


    September 2018
  25. DONNELLY DW, Kearney T, McCaughan E, Downing A, et al
    Treatment for erectile dysfunction among older men in Northern Ireland.
    Int J Clin Pract. 2018 Sep 17:e13259. doi: 10.1111/ijcp.13259.
    PubMed     Abstract available


    June 2018
  26. EVERAERT K, Anderson P, Wood R, Andersson FL, et al
    Nocturia is more bothersome than daytime LUTS: Results from an Observational, Real-life Practice Database including 8659 European and American LUTS patients.
    Int J Clin Pract. 2018;72:e13091.
    PubMed     Abstract available


    April 2018
  27. MULHALL JP, Hassan TA, Rienow J
    Sexual habits of men with ED who take phosphodiesterase 5 inhibitors: a survey conducted in 7 countries.
    Int J Clin Pract. 2018;72:e13074.
    PubMed     Abstract available


    March 2018
  28. GOLDSTEIN I, Chambers R, Tang W, Stecher V, et al
    Real-world observational results from a database of 48 million men in the United States: Relationship of cardiovascular disease, diabetes mellitus and depression with age and erectile dysfunction.
    Int J Clin Pract. 2018 Mar 22:e13078. doi: 10.1111/ijcp.13078.
    PubMed     Abstract available


  29. CAPPELLERI JC, Tseng LJ, Stecher VJ, Althof SE, et al
    Clinically important difference on the Erectile Dysfunction Inventory of Treatment Satisfaction questionnaire in patients with erectile dysfunction.
    Int J Clin Pract. 2018 Mar 1. doi: 10.1111/ijcp.13073.
    PubMed     Abstract available


    January 2018
  30. HACKETT G, Kirby M
    Erectile dysfunction and testosterone deficiency as cardiovascular risk factors?
    Int J Clin Pract. 2018 Jan 30. doi: 10.1111/ijcp.13054.
    PubMed     Abstract available


  31. LE HH, Salas RME, Gamaldo A, Billups KL, et al
    The utility and feasibility of assessing sleep disruption in a men's health clinic using a mobile health platform device: A pilot study.
    Int J Clin Pract. 2018;72.
    PubMed     Abstract available


    October 2017
  32. LIVINGSTON M, Kalansooriya A, Hartland AJ, Ramachandran S, et al
    Serum testosterone levels in male hypogonadism: Why and when to check-A review.
    Int J Clin Pract. 2017 Oct 5. doi: 10.1111/ijcp.12995.
    PubMed     Abstract available


    September 2017
  33. KAMINETSKY JC, Stecher V, Tseng LJ
    Quality of erections by age group in men with erectile dysfunction.
    Int J Clin Pract. 2017 Sep 11. doi: 10.1111/ijcp.12976.
    PubMed     Abstract available


    May 2017
  34. CHO S, Kwon SS, Lee KW, Yoo TK, et al
    A multicenter real-life study of the efficacy of an alpha-blocker with or without anticholinergic agent (imidafenacin) treatment in patients with lower urinary tract symptoms/benign prostatic hyperplasia and storage symptoms.
    Int J Clin Pract. 2017;71.
    PubMed     Abstract available


    April 2017
  35. OHL DA, Stecher V, Tseng LJ
    Ethnicity and age as factors in sildenafil treatment of erectile dysfunction.
    Int J Clin Pract. 2017 Apr 24. doi: 10.1111/ijcp.12945.
    PubMed     Abstract available


    March 2017
  36. HACKETT G, Kirby M, Edwards D, Jones TH, et al
    UK policy statements on testosterone deficiency.
    Int J Clin Pract. 2017 Mar 20. doi: 10.1111/ijcp.12901.
    PubMed     Abstract available


  37. GOLDSTEIN I, Stecher V, Carlsson M
    Treatment response to sildenafil in men with erectile dysfunction relative to concomitant comorbidities and age.
    Int J Clin Pract. 2017;71.
    PubMed     Abstract available


    December 2016
  38. MULHALL JP, Luo X, Zou KH, Stecher V, et al
    Relationship between age and erectile dysfunction diagnosis or treatment using real-world observational data in the USA.
    Int J Clin Pract. 2016;70:1012-1018.
    PubMed     Abstract available


    October 2016
  39. ERTEL P, Adalig B, Demircan I, Lartey B, et al
    Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey.
    Int J Clin Pract. 2016;70:870-880.
    PubMed     Abstract available


  40. MAGGI M, Wu FC, Jones TH, Jackson G, et al
    Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME).
    Int J Clin Pract. 2016;70:843-852.
    PubMed     Abstract available


    January 2016
  41. STEINKE E, Palm Johansen P, Fridlund B, Brostrom A, et al
    Determinants of sexual dysfunction and interventions for patients with obstructive sleep apnoea: a systematic review.
    Int J Clin Pract. 2016;70:5-19.
    PubMed     Abstract available


    October 2014
  42. HSU JC, Tang DH, Lu CY
    Risk-benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: a multiple criteria decision analysis.
    Int J Clin Pract. 2014 Oct 14. doi: 10.1111/ijcp.12548.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Andrology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: